Gain Therapeutics Overview
Gain Therapeutics Target Price
Analysts' 12-month price predictions for GANX.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.75
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-12-19 | Roth Capital | $10 |  471.4% upside |  |
| 2025-12-01 | H.C. WainwrightRaghuram Selvaraju | $8 | 357.1% upside | |
| 2025-10-07 | Maxim Group | $7 | 300% upside | |
| 2022-12-09 | Chardan Capital | $4 | 128.6% upside | |
| 2022-11-13 | BTIGThomas Shrader | $10 | 471.4% upside | |